Current Clinical Pharmacology
Title:Editorial: Are We in Need for Novel Therapeutics in Anxiety Disorders? (Thematic Issue: Non-Antidepressant Long Term Treatment of Anxiety Disorders)
Volume: 10 Issue: 2
Author(s): Rami Bou Khalil
Affiliation:
Export Options
About this article
Cite this article as:
Khalil Bou Rami, Editorial: Are We in Need for Novel Therapeutics in Anxiety Disorders? (Thematic Issue: Non-Antidepressant Long Term Treatment of Anxiety Disorders), Current Clinical Pharmacology 2015; 10 (2) . https://dx.doi.org/10.2174/157488471002150723144817
DOI https://dx.doi.org/10.2174/157488471002150723144817 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
The Critical Role of the Endocannabinoid System in Emotional Homeostasis: Avoiding Excess and Deficiencies
Mini-Reviews in Medicinal Chemistry Metabolomics of Medicinal Plants: The Importance of Multivariate Analysis of Analytical Chemistry Data
Current Computer-Aided Drug Design Cholinesterase Inhibitory Activities of Selected Halogenated Thiophene Chalcones
Central Nervous System Agents in Medicinal Chemistry Increased Susceptibility to Plasma Lipid Peroxidation in Alzheimer Disease Patients
Current Alzheimer Research Vascular Changes of the Retina and Choroid in Systemic Lupus Erythematosus: Pathology and Pathogenesis
Current Neurovascular Research Food as a Bariatric Drug
Current Pharmaceutical Design Small Heat Shock Proteins and Protein-Misfolding Diseases
Current Pharmaceutical Biotechnology Substance Use Portrayal in Oscar-nominated Movies
Current Drug Research Reviews Sublethal Total Body Irradiation Leads to Early Cerebellar Damage and Oxidative Stress
Current Neurovascular Research Endoplasmic Reticulum Stress as a Novel Therapeutic Target in Heart Diseases
Cardiovascular & Hematological Disorders-Drug Targets Amyloid PET and MRI in Alzheimers Disease and Mild Cognitive Impairment
Current Alzheimer Research Rofecoxib in Patients with Mild Cognitive Impairment: Further Analyses of Data from a Randomized, Double-Blind, Trial
Current Alzheimer Research Nerve Growth Factor, Stress and Diseases
Current Medicinal Chemistry An Insight into the Therapeutic Potential of Major Coffee Components
Current Drug Metabolism MicroRNA Pathways: An Emerging Role in Identification of Therapeutic Strategies
Current Gene Therapy Autoantibody Reaction to Myelin Basic Protein by Plasma Parvovirus B19 IgG in MS Patients
Protein & Peptide Letters The Antidepressant-like Effects of Estrogen-mediated Ghrelin
Current Neuropharmacology Preface [Hot Topic: Advances in the Four Pillars of Alzheimer Disease Research: Pathobiology, Genetics, Diagnosis, and Treatment (Debomoy K. Lahiri)]
Current Alzheimer Research D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity
Current Neuropharmacology M2 Protein-A Proton Channel of Influenza A Virus
Current Pharmaceutical Design